Submitted by Anonymous (not verified) on 14 October 2025 - 15:00
Human medicines European public assessment report (EPAR): Okedi, risperidone, Date of authorisation: 14/02/2022, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Okedi, risperidone, Date of authorisation: 14/02/2022, Revision: 4, Status: Authorised